Michael Charles Mistretta, D.D.S., M.D.
Oral & Maxillofacial Surgery (D.M.D.) · New York, NY
Michael Charles Mistretta, D.D.S., M.D. is an oral & maxillofacial surgery (d.m.d.) with a practice address in New York, New York, and NPI 1780602920, issued on Jul 17, 2006. Check the license (New York 240428-1, as entered in NPPES) with the New York board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Michael Charles Mistretta
- Credential
- D.D.S., M.D.
- Primary taxonomy
- Oral & Maxillofacial Surgery (D.M.D.) 204E00000X
- License numbers
- 240428-1 NY
049087-1 NY
Self-reported in NPPES; status is on the state search - Practice location
- 200 Central Park S, New York, NY 10019
- Phone
- (212) 245-3292
- Enumerated
- Jul 17, 2006
- Record last updated
- Apr 21, 2025
- Fax
- (212) 245-8758
- Entity
- Type 1 · individual
8 nearest oral & maxillofacial surgery (d.m.d.) records → All 92 in New York → Look up another NPI →
Also registered at 200 Central Park S
A shared address usually means a shared clinic or building; it does not show who employs whom.
- David Beller, D.M.D.Oral and Maxillofacial Surgery (Dentist)1881741585
- David Charig, RPAPhysician Assistant1538142468
- Kayhan Civelek, DDS MSPeriodontics1134348410
- Matthew Hislop, PAPhysician Assistant1174062491
- Lawrence Jaeger, DODermatology Physician1093711897
- Cristian Jager, DDSProsthodontics1467783464
Verify Michael Charles Mistretta in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich New York board licenses this profession
Search for license 240428-1Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
65% fewer Medicare Part D claims than the average oral & maxillofacial surgery (d.m.d.) in 2024
129 Medicare Part D claims for 53 beneficiaries, against an average of 366 among the 1,051 providers of this specialty who prescribed in Part D.
Most prescribed
- Ibuprofen33 claims
- Amoxicillin-Clavulanate Potass21 claims
- Amoxicillin20 claims
- Clindamycin Hcl18 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $3,296.20
2 payments; by number, the most common kind was food and beverage; the largest payer was Patterson Companies, Inc. The 800 providers of this specialty with any payment received $1,463.03 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Michael Charles Mistretta among 92 oral & maxillofacial surgery (d.m.d.) records in New York
Michael Charles Mistretta, D.D.S., M.D. is one of 92 oral & maxillofacial surgery (d.m.d.) records with a practice address in New York. 79% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 8% of them.
- NPI issued2006 · 8% of these records are older, 60% newer
- In a Medicare fileYes · 79% of these records are
- In the CMS Doctors and Clinicians fileNo · 40% of these records are
- Record last updated2025 · 52% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 204E00000X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Oral & Maxillofacial Surgery (D.M.D.) providers in New York
There are 92 oral & maxillofacial surgery (d.m.d.) records in New York.
All 92 in New York → Every provider in New York → Oral & Maxillofacial Surgery (D.M.D.) nationwide →
The 8 oral & maxillofacial surgery (d.m.d.) records with the nearest ZIP codes
- Jay Kim, DMD, MDNew York, NY 100191891920575
- Mallory Morel, DDS, MDNew York, NY 100191285226068
- Brian Schmidt, DMDNew York, NY 100171417906777
- Mohsin WazirNew York, NY 100211528444601
- Adam Abel, DMDNew York, NY 100221417310327
- Jeffrey Burkes, DDSNew York, NY 100221073690137
- Steven Cho, DDSNew York, NY 100221326034380
- Claudia Kaplan, DDSNew York, NY 100221801979240
Common questions
What is Michael Charles Mistretta, D.D.S., M.D.'s NPI number?
Michael Charles Mistretta, D.D.S., M.D.'s National Provider Identifier (NPI) is 1780602920, issued on Jul 17, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Michael Charles Mistretta, D.D.S., M.D. located?
The NPPES record lists a practice address at 200 Central Park S, New York, NY, 10019. Phone: (212) 245-3292. Providers update this record themselves, so call before visiting.
How can I verify Michael Charles Mistretta, D.D.S., M.D.'s license?
NPPES lists New York license number 240428-1, as entered by the provider. Search the New York board that licenses this profession; the NPPES record confirms identity only.
How much does Michael Charles Mistretta, D.D.S., M.D. prescribe under Medicare Part D?
In 2024, Michael Charles Mistretta, D.D.S., M.D. had 129 Medicare Part D claims for 53 beneficiaries; the average among oral & maxillofacial surgery (d.m.d.) prescribers was 366. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.